Cargando…
The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial
BACKGROUND: Increasing rates of breast cancer screening have been associated with an increasing frequency of non-palpable breast lesions detection. Preoperative breast lesion localization is essential for optimizing excision accuracy. This study aimed to evaluate the efficacy and safety of indocyani...
Autores principales: | Kim, Isaac, Choi, Hee Jun, Ryu, Jai Min, Lee, Se Kyung, Yu, Jong Han, Lee, Jeong Eon, Nam, Seok Jin, Shin, Hyuk Jai, Kim, Seok Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968200/ https://www.ncbi.nlm.nih.gov/pubmed/33726718 http://dx.doi.org/10.1186/s12893-021-01129-y |
Ejemplares similares
-
The efficacy and safety of an indocyanine green−hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial
por: Bang, Yoon Ju, et al.
Publicado: (2023) -
Development of a Nomogram to Predict N2 or N3 Stage in T1–2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
por: Kim, Isaac, et al.
Publicado: (2017) -
Erratum: Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
por: Kim, Isaac, et al.
Publicado: (2018) -
mass distribution in Luminos x-ray clusters
por: Smail, Ian, et al.
Publicado: (1994) -
Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
por: Choi, Hee Jun, et al.
Publicado: (2019)